Skip to main content
. 2018 Jul 17;19(7):2077. doi: 10.3390/ijms19072077

Figure 5.

Figure 5

MiRNA expression affected by selumetinib. RT-qPCR of hsa-let7f-5p, hsa-miR-146b-5p and, hsa-miR-146b-5p in TPC1, C643, BCPAP and 8505C cells treated for 48 h with 1 and 10 µM selumetinib. MiRNA transcripts were normalized to RNU6B. Results are expressed relative to the untreated control. Data represent mean ± SEM of experiments performed in triplicates. * p < 0.05 regarded as significant.